Literature DB >> 33770223

Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis.

Weon Jang1,2,3, Seongil Jo4, Ji Soo Song5,6,7, Hong Pil Hwang8, Seong-Hun Kim9.   

Abstract

PURPOSE: To compare the diagnostic performance of diffusion-weighted imaging (DWI), gradient-recalled echo-based magnetic resonance elastography (GRE-MRE), and spin-echo echo-planar imaging-based MRE (SE-EPI-MRE) in liver fibrosis staging.
METHODS: A systematic literature search was done to collect studies on the performance of DWI, GRE-MRE, and SE-EPI-MRE for diagnosing liver fibrosis. Pooled sensitivity, specificity, diagnostic odds ratio, positive and negative likelihood ratio, and a summary receiver operating characteristic (ROC) curve were estimated with a bivariate random effects model. Subgroup analyses on various study characteristics were performed.
RESULTS: Sixty studies with a total of 6620 patients were included in the meta-analysis. Pooled sensitivity and specificity of GRE-MRE and SE-EPI-MRE showed high diagnostic accuracy and did not differ significantly. The area under the summary ROC curve for all stages of fibrosis differed significantly between DWI (0.83-0.88) and either GRE-MRE (0.95-0.97) or SE-EPI-MRE (0.95-0.99). Substantial heterogeneity was detected for all three imaging methods.
CONCLUSIONS: Both GRE-MRE and SE-EPI-MRE are highly accurate for detection of each liver fibrosis stage, with high potential to replace liver biopsy. Although DWI had a moderate accuracy in distinguishing liver fibrosis, it could be regarded as an alternative to MRE, since it is widely available and easily implemented in routine liver MRI.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Diffusion-weighted image; Liver fibrosis; Magnetic resonance elastography; Meta-analysis

Mesh:

Year:  2021        PMID: 33770223     DOI: 10.1007/s00261-021-03055-2

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  58 in total

1.  Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.

Authors:  Bachir Taouli; Anuj J Tolia; Mariela Losada; James S Babb; Edwin S Chan; Michael A Bannan; Hillel Tobias
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

2.  Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mohamed Khashaba; Ahmed Abdalla; Mohamed Bayomy; Tarek Barakat
Journal:  Radiol Med       Date:  2014-05-21       Impact factor: 3.469

3.  MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.

Authors:  Luciana Costa-Silva; Silvia Marinho Ferolla; Agnaldo Soares Lima; Paula Vieira Teixeira Vidigal; Teresa Cristina de Abreu Ferrari
Journal:  Eur J Radiol       Date:  2017-11-11       Impact factor: 3.528

4.  Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging.

Authors:  Yi Wang; Daniel R Ganger; Josh Levitsky; Laura A Sternick; Robert J McCarthy; Zongming E Chen; Charles W Fasanati; Bradley Bolster; Saurabh Shah; Sven Zuehlsdorff; Reed A Omary; Richard L Ehman; Frank H Miller
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

5.  Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C.

Authors:  Anneloes E Bohte; Annikki de Niet; Louis Jansen; Shandra Bipat; Aart J Nederveen; Joanne Verheij; Valeska Terpstra; Ralph Sinkus; Karin M J van Nieuwkerk; Rob J de Knegt; Bert C Baak; Peter L M Jansen; Henk W Reesink; Jaap Stoker
Journal:  Eur Radiol       Date:  2013-10-25       Impact factor: 5.315

6.  Assessment of diffusion-weighted MR imaging in liver fibrosis.

Authors:  Laurence Annet; Frank Peeters; Jorge Abarca-Quinones; Isabelle Leclercq; Pierre Moulin; Bernard E Van Beers
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

7.  Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B.

Authors:  Qiang Lu; Changli Lu; Jiawu Li; Wenwu Ling; Xiaoying Qi; Du He; Jianping Liu; Tianfu Wen; Hong Wu; Hongguang Zhu; Yan Luo
Journal:  Radiology       Date:  2016-02-17       Impact factor: 11.105

8.  Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes.

Authors:  Won Chang; Jeong Min Lee; Jeong Hee Yoon; Joon Koo Han; Byung Ihn Choi; Jung Hwan Yoon; Kyoung Bun Lee; Kwang-Woong Lee; Nam-Joon Yi; Kyung-Suk Suh
Journal:  Radiology       Date:  2016-02-04       Impact factor: 11.105

9.  Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C.

Authors:  Wen-Pei Wu; Chen-Te Chou; Ran-Chou Chen; Chih-Wei Lee; Kwo-Whei Lee; Hwa-Koon Wu
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

10.  MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.

Authors:  Jinho Jung; Rohan R Loomba; Kento Imajo; Egbert Madamba; Sanil Gandhi; Ricki Bettencourt; Seema Singh; Carolyn Hernandez; Mark A Valasek; Cynthia Behling; Lisa Richards; Katie Fowler; Claude B Sirlin; Atsushi Nakajima; Rohit Loomba
Journal:  Gut       Date:  2020-11-19       Impact factor: 23.059

View more
  1 in total

1.  Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study.

Authors:  Wei Xu; Bolun Li; Zhanwei Yang; Jingdong Li; Fei Liu; Yu Liu
Journal:  J Hepatocell Carcinoma       Date:  2022-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.